Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Maspero

Showing results (21-30 of 57) with videos related to

Pageof 6
Sort By:
The European Respiratory Journal|July 16, 2021
Effect of exacerbation history on clinical response to dupilumab in moderate-to-severe uncontrolled asthmaJonathan Corren, Constance H Katelaris, Mario Castro, et al.
Allergy|April 27, 2021
Dupilumab efficacy in adolescents with uncontrolled, moderate-to-severe asthma: LIBERTY ASTHMA QUESTJorge F Maspero, John Mark FitzGerald, Ian D Pavord, et al.
Respiratory Medicine|September 2, 2023
Dupilumab efficacy in high sleep disturbance management among patients with type 2 asthmaJorge F Maspero, Shirin Shafazand, Jeremy Cole, et al.
The Journal of Allergy and Clinical Immunology. in Practice|August 29, 2024
Dupilumab Efficacy in Children With Type 2 Asthma Receiving High- to Medium-Dose Inhaled Corticosteroids (VOYAGE)Jorge F Maspero, Martti A Antila, Antoine Deschildre, et al.
Allergy|August 30, 2021
Efficacy and safety of dupilumab in patients with uncontrolled severe chronic rhinosinusitis with nasal polyps and a clinical diagnosis of NSAID-ERD: Results from two randomized placebo-controlled phase 3 trialsJoaquim Mullol, Tanya M Laidlaw, Claus Bachert, et al.
ERJ Open Research|October 20, 2023
Impact of exacerbation history on long-term efficacy of dupilumab in patients with asthmaJonathan Corren, Constance H Katelaris, Mario Castro, et al.
The Journal of Allergy and Clinical Immunology. in Practice|August 26, 2022
Dupilumab Is Effective in Patients With Moderate-to-Severe Uncontrolled GINA-Defined Type 2 Asthma Irrespective of an Allergic Asthma PhenotypeKlaus F Rabe, J Mark FitzGerald, Eric D Bateman, et al.
American Journal of Respiratory and Critical Care Medicine|February 8, 2024
Biomarkers Associated with Lung Function Decline and Dupilumab Response in Patients with AsthmaIan D Pavord, Lucia De Prado Gómez, Guy Brusselle, et al.
Journal of Asthma and Allergy|April 5, 2023
Health-Related Quality of Life Impairment Among Patients with Severe Chronic Rhinosinusitis with Nasal Polyps in the SINUS-24 TrialJorge F Maspero, Asif H Khan, Carl Philpott, et al.
Advanced Materials (Deerfield Beach, Fla.)|July 23, 2025
Standalone Integrated Magnonic DevicesM Cocconcelli, F Maspero, A Micelli, et al.
Pageof 6

Showing results (21-30 of 57) with videos related to

Sort By:
Pageof 6
The European Respiratory Journal|July 16, 2021
Effect of exacerbation history on clinical response to dupilumab in moderate-to-severe uncontrolled asthmaJonathan Corren, Constance H Katelaris, Mario Castro, et al.
Allergy|April 27, 2021
Dupilumab efficacy in adolescents with uncontrolled, moderate-to-severe asthma: LIBERTY ASTHMA QUESTJorge F Maspero, John Mark FitzGerald, Ian D Pavord, et al.
Respiratory Medicine|September 2, 2023
Dupilumab efficacy in high sleep disturbance management among patients with type 2 asthmaJorge F Maspero, Shirin Shafazand, Jeremy Cole, et al.
The Journal of Allergy and Clinical Immunology. in Practice|August 29, 2024
Dupilumab Efficacy in Children With Type 2 Asthma Receiving High- to Medium-Dose Inhaled Corticosteroids (VOYAGE)Jorge F Maspero, Martti A Antila, Antoine Deschildre, et al.
Allergy|August 30, 2021
Efficacy and safety of dupilumab in patients with uncontrolled severe chronic rhinosinusitis with nasal polyps and a clinical diagnosis of NSAID-ERD: Results from two randomized placebo-controlled phase 3 trialsJoaquim Mullol, Tanya M Laidlaw, Claus Bachert, et al.
ERJ Open Research|October 20, 2023
Impact of exacerbation history on long-term efficacy of dupilumab in patients with asthmaJonathan Corren, Constance H Katelaris, Mario Castro, et al.
The Journal of Allergy and Clinical Immunology. in Practice|August 26, 2022
Dupilumab Is Effective in Patients With Moderate-to-Severe Uncontrolled GINA-Defined Type 2 Asthma Irrespective of an Allergic Asthma PhenotypeKlaus F Rabe, J Mark FitzGerald, Eric D Bateman, et al.
American Journal of Respiratory and Critical Care Medicine|February 8, 2024
Biomarkers Associated with Lung Function Decline and Dupilumab Response in Patients with AsthmaIan D Pavord, Lucia De Prado Gómez, Guy Brusselle, et al.
Journal of Asthma and Allergy|April 5, 2023
Health-Related Quality of Life Impairment Among Patients with Severe Chronic Rhinosinusitis with Nasal Polyps in the SINUS-24 TrialJorge F Maspero, Asif H Khan, Carl Philpott, et al.
Advanced Materials (Deerfield Beach, Fla.)|July 23, 2025
Standalone Integrated Magnonic DevicesM Cocconcelli, F Maspero, A Micelli, et al.
Pageof 6